Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

被引：33

作者：

Kosmider, Olivier ^{[1
]}

Passet, Marie ^{[1
]}

Santini, Valeria ^{[2
]}

Platzbecker, Uwe ^{[3
]}

Andrieu, Valerie ^{[4
]}

Zini, Gina ^{[5
]}

Beyne-Rauzy, Odile ^{[6
]}

Guerci, Agnes ^{[7
]}

Masala, Erico ^{[8
]}

Balleari, Enrico ^{[9
]}

Bulycheva, Ekaterina ^{[3
]}

Dreyfus, Francois ^{[10
]}

Fenaux, Pierre ^{[11
]}

Fontenay, Michaela ^{[1
]}

Park, Sophie ^{[12
]}

机构：

[1] Hop Cochin, AP HP, Hematol Biol, Paris, France

[2] Univ Florence, AOU Careggi, Hematol, I-50121 Florence, Italy

[3] Univ Hosp Carl Gustav Dresden, Dresden, Germany

[4] Hop Bichat Claude Bernard, AP HP, Hematol Biol, Paris, France

[5] Univ Cattolica Sacro Cuore, Rome, Italy

[6] Oncopole, IUCT, Toulouse, France

[7] Hop Brabois, Nancy, France

[8] Univ Florence, Florence, Italy

[9] IRCCS AOU San Martino IST Genova, Genoa, Italy

[10] Hop Cochin, Serv Hematol, Paris, France

[11] Hop St Louis, Serv Hematol Seniors, Paris, France

[12] Univ Grenoble Alpes, CHU Grenoble Alpes, Clin Univ Hematol, Grenoble, France

来源：

HAEMATOLOGICA | 2016年 / 101卷 / 07期

关键词：

myelodysplastic syndromes; cytogenetics and molecular genetics; red cells; SURVIVAL; IMPACT; MODEL;

D O I：

10.3324/haematol.2016.142695

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：280 / 283

页数：4

共 50 条

[1] Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes
Caballero, Juan Carlos
Davila, Julio
Lopez-Pavia, Maria
Such, Esperanza
Bernal, Teresa
Ramos, Fernando
Calabuig, Marisa
Sanchez, Jesus Maria Hernandez
Pomares, Helena
Barba, Mercedes Sanchez
Abaigar, Maria
Gonzalez, Bernardo
Merchan, Brayan
Sancho-Tello, Reyes
Callejas, Marta
Munoz-Novas, Carolina
Cervero, Carlos
Sanz, Guillermo
Rivas, Jesus Maria Hernandez
Campelo, Maria Diez
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2024, 15
[2] Validation of Predictive Models for Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndromes
Gowanlock, Zachary
Sriram, Swetha
Martin, Alison
Lazo-Langner, Alejandro
BLOOD, 2015, 126 (23)
[3] Erythropoiesis-stimulating agents in myelodysplastic syndromes
Hellstrom-Lindberg, Eva
LEUKEMIA & LYMPHOMA, 2010, 51 (07) : 1155 - 1156
[4] Characteristics and Distribution of Erythroid Progenitors and Precursors Correlate with Erythropoiesis Stimulating Agents (ESAs) Response in Lower Risk Myelodysplastic Syndromes
Raddi, Marco Gabriele Gabriele
Bencini, Sara
Peruzzi, Benedetta
Caporale, Roberto
Consagra, Angela
Attardi, Enrico
Rigodanza, Luca
Amato, Cristina
Sanna, Alessandro
Brogi, Alice
Tofacchi, Elena
Cassari, Margherita
de Pourcq, Sven
Mattiuz, Giorgio
Annunziato, Francesco
Santini, Valeria
BLOOD, 2022, 140 : 9777 - 9778
[5] Erythropoiesis-stimulating agents are effective in myelodysplastic syndromes, but are they safe?
Steensma, David P.
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (01) : 3 - 5
[6] MYELODYSPLASTIC SYNDROMES AND ERYTHROPOIESIS STIMULATING AGENTS (ESAS) : EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE
Cerchione, C.
Vitagliano, O.
Cerciello, G.
Pareto, A. E.
Di Perna, M.
Soriente, I.
D'Arco, A. M.
Danise, P.
Alfinito, F.
Pane, F.
HAEMATOLOGICA, 2016, 101 : S115 - S115
[7] MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS: EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE
Cerchione, C.
Vitagliano, O.
Simeone, L.
Pareto, A. E.
Soriente, I.
D'arco, A. M.
Danise, P.
Alfinito, F.
Pane, F.
LEUKEMIA RESEARCH, 2015, 39 : S104 - S104
[8] MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS: EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE
Cerchione, C.
Vitagliano, O.
Simeone, L.
Pareto, A. E.
Cerciello, G.
Soriente, I.
D'Arco, A. M.
Danise, P.
Alfinito, F.
Pane, F.
HAEMATOLOGICA, 2015, 100 : 166 - 167
[9] MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS : EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE
Cerchione, C.
Vitagliano, O.
Simeone, L.
Pareto, A. E.
Soriente, I.
D'Arco, A. M.
Danise, P.
Alfinito, F.
Pane, F.
HAEMATOLOGICA, 2015, 100 : 482 - 482
[10] Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes
Smith, Sheila Weiss
Sato, Masayo
Gore, Steven D.
Baer, Maria R.
Ke, Xuehua
McNally, Diane
Davidoff, Amy
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (01): : 15 - 20

← 1 2 3 4 5 →